| Hans-Günter Meyer-Thompson | Covid-19
Impact of guidance issued during COVID-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland: An interrupted time series analysis.
Impact of guidance issued during COVID-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland: An interrupted time series analysis.
Durand L, Keenan E, Bennett K, Crowley D, O'Hara A, Cousins G.
Int J Drug Policy. 2026 Jul;153:105321. doi: 10.1016/j.drugpo.2026.105321. Epub 2026 May 9. Erratum in: Int J Drug Policy. 2026 Jun 5;154:105342. doi: 10.1016/j.drugpo.2026.105342. PMID: 42107258.
https://www.sciencedirect.com/science/article/pii/S0955395926001738